disease 1,609 words KG: ent-dise-01761651 2026-03-23
kind:diseasesection:diseasesstate:published
Contents

LATE (Limbic-Predominant Age-Related TDP-43 Encephalopathy)

Disease Info
TDP-43 PathologyPhosphorylated, ubiquitinated, and truncated TDP-43 inclusions
Limbic PredominancePrimary involvement of amygdala, hippocampus, and entorhinal cortex
Age AssociationTypically onset after age 80
Clinical PhenotypeAmnestic syndrome resembling AD but with distinct progression
Age 70-79Approximately 5-10% prevalence
Age 80-89Approximately 15-20% prevalence
Age 90+Up to 25-30% prevalence in some cohorts
DatabasesOMIMOrphanetClinicalTrialsPubMed

Knowledge Graph

Related Hypotheses (30)

Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51
Glycosaminoglycan Template Disruption Approach
Score: 0.46
SASP-Mediated Complement Cascade Amplification
Score: 0.70
TREM2-Dependent Microglial Senescence Transition
Score: 0.69
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68

Related Analyses (9)

Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived
Extracellular vesicle biomarkers for early AD detection
neurodegeneration · completed
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived